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This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based 
research. The summary is not intended to be a comprehensive summary of available evidence on 
COVID-19 but aims to make original documents easily accessible to decision makers which, if 
relevant to them, they should go to before making decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
19.08.2020 Effects of 
COVID-19 
on the 
nervous 
system 
Cell | Review 
• A critical appraisal 
of the potential for 
neurotropism and 
mechanisms of 
neuropathogenesis 
of SARS-CoV-2, as 
they relate to the 
acute and chronic 
neurological 
consequences of 
the infection 
• Includes 
outstanding 
questions 
Nervous 
system 
18.08.2020 Effects of a 
major 
deletion in 
the SARS-
CoV-2 
genome on 
the severity 
of infection 
and the 
inflammatory 
response: an 
The Lancet | 
Article 
• Deletions in open 
reading frame 8 
(ORF8) is a hotspot 
for coronavirus 
mutation 
• The clinical effect of 
deletions in this 
region appears to 
be a milder 
infection with less 
systemic release of 
proinflammatory 
Genome 
deletion 
observational 
cohort study 
cytokines and a 
more effective 
immune response 
to SARS-CoV-2 
• Further study of 
these variants 
could have 
implications for 
development of 
treatments and 
vaccines 
17.08.2020 COVID-19 
and 
multisystem 
inflammatory 
syndrome in 
children and 
adolescents 
The Lancet 
Infectious 
Diseases | 
Review 
• A review of the 
epidemiology, 
causes, clinical 
features and 
current treatment 
protocols for 
multisystem 
inflammatory 
syndrome in 
children and 
adolescents 
associated with 
C19 
• Also a discussion 
on the possible 
underlying 
pathophysiological 
mechanisms for 
C19-induced 
inflammatory 
processes, which 
can lead to organ 
damage in 
paediatric patients 
who are severely ill 
• This provides 
evidence for the 
need to develop a 
clear case definition 
and treatment 
protocol for this 
new condition 
Multisystem 
inflammatory 
syndrome, 
children, 
adolescents 
17.08.2020 SARS-CoV-2 
renal tropism 
associates 
The Lancet | 
Correspondence 
• SARS-CoV-2 has 
been found in the 
kidney but the 
clinical effect 
remains unclear 
renal 
with acute 
kidney injury 
• Data from a post-
mortem series of 63 
patients who had 
SARS-CoV-2 
respiratory 
infection, linking 
SARS-CoV-2 renal 
tropism to clinical 
outcome and acute 
kidney injury 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
18.08.2020 Comparison 
of molecular 
testing 
strategies for 
COVID-19 
control: a 
mathematical 
modelling 
study 
The Lancet 
Infectious 
Diseases | 
Article 
• WHO has called for 
increased C19 testing, 
but countries have taken 
different approaches and 
the effectiveness of 
alternative strategies is 
unknown  
• This modelling study 
investigated the potential 
impact of different 
testing and isolation 
strategies  SARS-CoV-2 
transmission 
• The expected 
effectiveness of different 
testing strategies was 
defined as the 
percentage reduction in 
R 
• Authors conclude that 
molecular testing can 
play an important role in 
prevention of SARS-
CoV-2 transmission, 
especially among 
healthcare workers and 
other high-risk groups, 
but no single strategy 
will reduce R below 1 at 
current levels of 
population immunity 
Molecular 
testing 
strategies 
13.08.2020 Contact 
settings and 
risk for 
transmission 
Annals 
Internal 
• Risk for transmission of 
SARS-CoV-2 to close 
contacts of infected 
persons has not been 
well estimated 
Transmission 
risk, close 
contacts 
in 3410 close 
contacts of 
patients with 
COVID-19 in 
Guangzhou, 
China: A 
prospective 
cohort study 
Medicine | 
Article 
• This prospective cohort 
study evaluates the risk 
for transmission of 
SARS-CoV-2 to close 
contacts in different 
settings 
• Compared with the 
household setting 
(10.3%), the secondary 
attack rate was lower for 
exposures in healthcare 
settings (1.0% OR 0.09 
[CI, 0.04 to 0.20]) and on 
public transportation 
(0.1% OR 0.01 [CI 0.00 
to 0.08]) 
• The secondary attach 
rate increased with the 
severity of index cases 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
18.08.2020 Digital 
contact 
tracing 
technologies 
in 
epidemics: a 
rapid review 
Cochrane 
Systematic 
Review - 
Rapid 
• A rapid review on the 
effectiveness of digital 
solutions to contact 
tracing during infectious 
disease outbreaks 
• The effectiveness of 
digital solutions is largely 
unproven as there are 
very few published data in 
real-world outbreak 
settings 
• None of the included 
studies assessed digital 
plus manual contact 
tracing with digital contact 
tracing alone 
• Digital solutions may have 
equity implications for at-
risk populations with poor 
internet access and poor 
access to digital 
technology 
Digital 
contact 
tracing 
19.08.2020 Automated 
and partly 
automated 
contact 
tracing: a 
The Lancet 
Digital Health 
| Review 
• A SR of automated or 
partly automated contact 
tracing 
• No empirical evidence of 
the effectiveness of 
Digital 
contact 
tracing 
systematic 
review to 
inform the 
control of 
COVID-19 
automated contact tracing 
was identified 
• Concerns regarding 
privacy and equity should 
be considered 
• Well-designed prospective 
studies are needed given 
gaps in evidence of 
effectiveness.  
• Large-scale manual 
contact tracing is 
therefore still key in most 
contexts 
17.08.2020 SARS-CoV-
2 infection 
among 
community 
health 
workers in 
India before 
and after 
use of face 
shields 
JAMA | 
Research 
Letter 
• Face shields have been 
proposed to prevent 
transmission of SARS-
CoV-2 in the community 
but data are lacking 
• Here the transmission in a 
community setting before 
and after the use of face 
shields is described 
• The study found no 
SARS-CoV-2 infections 
among community health 
workers after the addition 
of face shields to their 
personal protective 
equipment 
• The before-after design is 
a limitation and further 
investigation of face 
shields in community 
settings is warranted 
Face 
shields, 
community 
transmission 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
 14.08.2020  Implications 
of sex 
differences in 
immunity for 
SARS-CoV-2 
pathogenesis 
and design of 
therapeutic 
interventions 
 Cell| Review 
• Men present more 
frequently with severe 
manifestations of 
COVID-19 and are at 
higher risk for death 
• Sex differences in 
immunity contribute to 
better control of SARS-
CoV-2 in women 
• Immune-mediated 
tissues repair 
mechanisms differ 
between the sexes 
 Sex 
differences, 
immunity 
14.08.2020 Tocilizumab 
among 
patients with 
COVID-19 in 
the intensive 
care unit: a 
multicentre 
observational 
study 
 
The Lancet 
Rheumatology 
| Article 
 
• Tocilizumab, a 
monoclonal antibody 
directed against the IL-6 
receptor, could mitigate 
the cytokine storm 
syndrome associated 
with severe C19 
• This observational study 
found that patients with 
C19 requiring ICU 
support who received 
tocilizumab had reduced 
mortality 
• Awaiting results of 
ongoing randomised 
controlled trials 
Tocilizumab, 
mortality 
Vaccines 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 20.08.2020 RNA-based 
COVID-19 
vaccine 
BNT162b2 
selected for 
a pivotal 
efficacy 
study 
 medRxiv | 
preprint (not 
peer-reviewed) 
• Additional safety and 
immunogenicity data from 
the US phase 1 trial that 
supported selection of the 
vaccine candidate 
• Results support selection 
of the BNT162b2 vaccine 
candidate for phase 2/3 
large-scale safety and 
efficacy evaluation, 
currently underway 
Phase 1, 
RNA 
vaccine 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 19.08.2020 Knowledge 
and 
perception 
of COVID-
19, 
prevalence 
of pre-
existing 
conditions 
and access 
 medRxiv | 
preprint (not 
peer 
reviewed) 
• There are ‘immense gaps’ 
in the knowledge and 
perceptions of C19 and 
access to treatment and 
preventative services 
among individuals living in 
Somali IDP camps 
• Huge resources are needed 
to adequately address C19 
in Somalia, starting with 
educating those most 
vulnerable to infection 
 Knowledge 
gap, 
perception 
to essential 
resources 
and health 
services in 
Somali IDP 
camps 
17.08.2020 Behavioural 
preventive 
measures 
and the use 
of 
medicines 
and herbal 
products 
among the 
public in 
response to 
Covid-19 in 
Bangladesh: 
a cross-
sectional 
study 
medRxiv | 
preprint (not 
peer 
reviewed) 
 
• Cross-sectional survey of 
1222 people 
• Gender, age and fear of 
C19 were associated with 
the use of both preventive 
medicines and herbal 
products 
• Paracetamol, Fexofenadine 
and zinc supplements were 
used most often for the 
management of C19 
related symptoms 
• Most participants sought 
information from non-
medical sources 
• Potentially inappropriate 
and unnecessary use of 
drugs were identified 
Prevention, 
medicines, 
herbal 
products 
16.08.2020 Knowledge, 
practice and 
associated 
factors 
towards the 
prevention 
of COVID-
19 among 
high-risk 
groups: a 
cross-
sectional 
study in 
Addis 
Ababa, 
Ethiopia 
 
medRxiv | 
preprint (not 
peer 
reviewed) 
 
• This study found that there 
was moderate knowledge 
about transmission modes 
and prevention mechanism 
• Also moderate practice of 
measures that contribute 
towards the prevention of 
C19 among these priority 
high-risk communities of 
Addis Ababa 
• There is an need to fill this 
knowledge gap to improve 
prevention practices and 
control the spread of C19 
• Female public figures and 
religious leaders could help 
support raising awareness 
Knowledge 
gap 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type 
Sept 2020 Improving handwashing habits and 
household air quality in Africa after COVID-
19 
The Lancet Global Health | 
Comment 
Sept 2020 Water and sanitation in a post-COVID world The Lancet Global Health | 
Editorial 
20.08.2020 Airborne transmission of covid-19 BMJ | Editorial 
19.08.2020 Progress report on the coronavirus 
pandemic 
Nature | Editorial 
19.08.2020 Modelling the manufacturing process for 
COVID-19 vaccines: our approach  
CGD | Blog 
18.08.2020 Community engagement for successful 
COVID-19 pandemic response: 10 lessons 
from Ebola outbreak responses in Africa 
BMJ Global Health | Commentary 
18.08.2020 Accelerating genomics-based surveillance 
for COVID-19 response in Africa 
The Lancet Microbe | Comment 
17.08.2020 The perils of preprints BMJ | Editorial 
15.08.2020 COVID-19 worsens in Zimbabwe’s health 
crisis 
The Lancet | World Report 
15.08.2020 Humanitarian crises in a global pandemic The Lancet | Editorial 
15.08.2020 COVID-19 combination prevention requires 
attention to structural drivers 
The Lancet | Correspondence 
15.08.2020 Emerging pandemic diseases: how we got 
to COVID-19 
Cell | Perspective 
14.08.2020 Finding the best covid-19 vaccine should 
not be a race 
BMJ | Opinion 
13.08.2020 COVID-19 in Kenya: 150 days of learning BMJ Global Health | Blog 
13.08.2020 How contextual issues are jeopardising the 
COVID-19 response in Mali? 
BMJ Global Health | Blog 
13.08.2020 Sex differential in COVID-19 mortality varies 
markedly by age 
The Lancet | Correspondence 
11.08.2020 COVID-19 pandemic more than a century 
after the Spanish flu 
The Lancet Infectious Diseases | 
Correspondence 
11.08.2020 The pandemic appears to have spared 
Africa so far. Scientists are struggling to 
explain why 
Science | News 
10.08.2020 Digital public health and COVID-19 The Lancet Public Health | 
Comment 
05.08.2020 Innovation during COVID-19: Applying 
global mental health lessons from 
humanitarian settings to high resource 
settings 
Health Policy and Planning 
Debated | Blog 
2020 COVID-19: Implications of cross-border 
traffic in Eastern and Southern Africa 
SSHAP | Infographics 
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Dashboards & Trackers 
Cases & 
deaths: Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living evidence & 
policy maps 
Current research 
including trials 
  Diagnostics   Treatments   Vaccines 
WHO sitreps  WHO Africa  Ghana  COVID-NMA  WHO    FIND SARS-
CoV-2 Test 
Tracker 
  Global COVID-
19 Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard  
African 
Arguments  
Indonesia  EPPI Centre  WHO International 
Clinical Trials Registry 
Platform (ICTRP)  
 FIND SARS-CoV-
2 Diagnostics: 
performance data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM  
Johns Hopkins 
University  
European 
CDC  
Nigeria 
CDC  
Norwegian 
Institute of Public 
Health  
Cytel   Serology-based 
tests for COVID-
19 
  Solidarity trial  COVID-19 
Oxford 
Vaccine Trial 
WEF    Sierra 
Leone  
 Oxford C19 
Government 
Response Tracker 
(OxCGRT) 
US NIH   Our World in 
Data: C19 Testing 
  COVID-19 
Therapeutics 
Accelerator 
 COVID-19 
Vaccine 
Tracker 
Our World in 
Data  
  Singapore   Our World in 
Data: C19 Policy 
responses 
COVID-evidence        
Global 5050    UK   IFPRI COVID-19 
Policy Response 
Portal 
Cochrane        
CEBM, 
University of 
Oxford 
  US   COVID-19 Primer Clinicaltrials.gov        
Humanitarian 
Data Exchange  
     NIH LitCovid  UKCDR       
Information is 
Beautiful  
     WHO COVID-19 
Database 
        
LSHTM                
HealthMap 
(cases) 
              
The Commons 
Project 
              
SeroTracker                
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C19 Resource Hubs 
Global  Regional 
& Country 
Academic journals 
& Publishers 
Institutes/Centres/
Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO 
COVID-19 
pandemic  
Africa 
CDC 
Annals of Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicati
on 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of the 
WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University Press 
ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academy 
of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparedne
ss 
Innovations 
  Social 
Developm
ent Direct 
C19 blog 
series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and 
Eastern 
Africa 
COVID-19 
Digest 
Health Policy and 
Planning  
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Governme
nt 
JAMA Network Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The Lancet  HEART     
UNESCO   medRxiv and 
bioRxiv (Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   SAGE journals  Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David 
Nabarro 
  Springer Nature       
Reliefweb   SSRN (Preprints)        
Humanitarian 
OpenStreetM
ap Team 
  Wiley       
Global 
Partnership 
for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global 
Impact Study 
    
  
GISAID           
Online learning & events 
 Date Title/URL Online 
learning/event 
Duration Lead 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid weekly search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary 
research papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease 
control and health system responses are included. Articles related to tackling the secondary impacts on other 
sectors are not included. Additional commentaries, opinions, and commissioned pieces are selected based on 
relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report  
This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before making 
decisions. The HES are not intended to replace medical or professional advice and the researcher or the K4D 
consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES alone. 
K4D services are provided by a consortium of leading organisations working in international development, led by 
the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds Nuffield 
Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), University of 
Birmingham International Development Department (IDD) and the University of Manchester Humanitarian and 
Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. It is 
licensed for non-commercial purposes only. K4D cannot be held responsible for errors, 
omissions or any consequences arising from the use of information contained in this health 
evidence summary. Any views and opinions expressed do not necessarily reflect those of 
DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020.               
 
 
